PATENT CLAIM ANALYSIS

Application Number: 16201117
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-08
Patent Classification: ["546", "200000"]

Abstract:
The invention provides novel asymmetric and symmetric bisaminoquinolmes and related compounds, methods of treatment and syntheses. The novel compounds exhibit effective anticancer activity and are useful in the treatment of a variety of autophagy-related disorders.

Claim (Index 8):
The compound according to  claim 5  wherein L is an alkylene group containing from 6 to 20 methylene groups (C 6 -C 20  alkylene group).

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.35714
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15502330', '15384823', '15890040', '15580978', '14396956']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7940396442198012
- 35 USC 102 Novelty (BERT): 0.6085567430980003
- Combined Prediction Score: 0.7754913541076212
- Mean Citation Score: 356.153908
- Max Citation Score: 619.825
- Similarity Product: 465.9511115208268

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test